Establishment of two novel organoid lines from patients with combined hepatocellular cholangiocarcinoma
- 6 December 2024
- journal article
- research article
- Published by Springer Nature in Human Cell
- Vol. 38 (1) , 1-10
Abstract
Combined hepatocellular cholangiocarcinoma (cHCC-CCA) is a unique subtype of primary liver cancer displaying both hepatocytic and cholangiocytic differentiation. The development of effective treatments for cHCC-CCA remains challenging because of its high heterogeneity and lack of a suitable model system. Using a three-dimensional culture system, we successfully established two novel cHCC-CCA organoid lines from patients undergoing surgical resection for primary liver cancer. cHCC-CCA organoid lines were authenticated by fingerprint analysis, and their morphology, growth kinetics, and anchorage-independent growth were also characterized. Hematoxylin and eosin staining and immunohistochemical analysis showed that the cHCC-CCA organoids preserved the growth pattern, differentiation grade, and phenotypic characteristics of their parental tumors. Whole-exome sequencing demonstrated that patient-derived cHCC-CCA organoid lines retained the genetic alterations identified in their original tumors. Subcutaneous tumors developed in immunodeficient mice after injection of cHCC-CCA organoids. Histologically, the xenografts recapitulated the features of the original cHCC-CCA tumors, harboring both HCC and intrahepatic cholangiocarcinoma components within the same tumor. The establishment of patient-derived cHCC-CCA organoid lines with high tumorigenicity provides a valuable resource for the mechanistic investigation and drug development of this disease.Keywords
All Related Versions
Funding Information
- the Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences (2019PT320015)
- Young Medical Key Talents Foundation of Jiangsu Province (ZDRCA2016097)
This publication has 25 references indexed in Scilit:
- Genomic landscape of Chinese patients with hepatocellular carcinoma using next-generation sequencing and its association with the prognosisAnnals of Hepatology, 2023
- Heterogeneity, inherent and acquired drug resistance in patient-derived organoid models of primary liver cancerCellular Oncology, 2022
- Organoids and Spheroids as Models for Studying Cholestatic Liver Injury and CholangiocarcinomaHepatology, 2021
- Updates in the diagnosis of combined hepatocellular-cholangiocarcinomaHuman Pathology, 2020
- Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular SubtypesCancer Cell, 2019
- Genomic profiling of combined hepatocellular‐cholangiocarcinoma reveals similar genetics to hepatocellular carcinomaThe Journal of Pathology, 2019
- A Living Biobank of Breast Cancer Organoids Captures Disease HeterogeneityCell, 2018
- Tumor Organoids as a Pre-clinical Cancer Model for Drug DiscoveryCell Chemical Biology, 2017
- Chemokine CCL15 Mediates Migration of Human Bone Marrow-Derived Mesenchymal Stem Cells Toward Hepatocellular CarcinomaStem Cells, 2016
- Establishment and characterization of a human combined hepatocholangiocarcinoma cell line and its heterologous transplantation in nude miceHepatology, 1987